Breathing mask sedation trial for agitated adults
Treatments studied
Part of Lungs & breathing clinical trials.
This trial tests whether adding a sedative called dexmedetomidine to non-invasive ventilation (a breathing mask) helps adults who are agitated or uncomfortable while on the mask. It aims to improve comfort and avoid the need for a breathing tube.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are currently using a non-invasive breathing mask (NIV) for acute breathing problems
- You are in the ICU, a step-down unit, or the emergency department with plans for close monitoring
- You feel very agitated, restless, or uncomfortable with the mask, or you have asked to have it removed
- You do not have a pacemaker that causes very slow heart rate or heart block
- You are not pregnant, breastfeeding, or allergic to dexmedetomidine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a sedative called dexmedetomidine can reduce agitation in ICU patients when they are being weaned off a breathing tube. If you experience restlessness or agitation during the weaning process, this medication might help you stay calm.
This study tests an early sedation medicine called dexmedetomidine in patients 65 and older who need a breathing tube. It may help reduce confusion and time on the machine compared to usual care.
This trial tests a new way to manage sedation (medication to keep you calm and comfortable) for people on a breathing machine. The goal is to see if adjusting sedation based on your breathing effort leads to better outcomes and shorter time on the machine.
This trial tests whether combining two sedative medications, esketamine and dexmedetomidine, is safer and more effective than using dexmedetomidine alone for treating hyperactive delirium in ICU patients who need breathing support. If you or a loved one are experiencing severe confusion and agitation while on a breathing machine, this study may offer a new treatment option.
This study tests a drug called dexmedetomidine to help sedate children who need a breathing machine for more than 12 hours. It may reduce confusion (delirium) compared to usual sedatives.
This study tests whether a drug called dexmedetomidine (a sedative) can help calm patients with severe brain injury who are on a breathing machine in the intensive care unit. If you or your loved one is in this situation, this treatment might reduce agitation and improve recovery.
Hear when a new Non-invasive Ventilation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.